Jornal Vascular Brasileiro
Jornal Vascular Brasileiro
Case Report

Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2

Alprostadil associado a heparina de baixo peso molecular para o tratamento da isquemia de membros causada por SARS-CoV2

Marcos Antonio Bonacorso Manhanelli Filho; Eliud Garcia Duarte Júnior; Jamil Victor de Oliveira Mariuba; Fábio Linardi; José Augusto Costa; Julio Cesar Gali; Winston Bonetti Yoshida; Julio Cesar Gali Filho

Downloads: 5
Views: 311


Abstract: The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.


COVID-19, thromboembolism, limb ischemia, arterial thrombosis, heparin


Resumo: A atual pandemia de coronavírus já gerou danos profundos ao redor do mundo, causando grande quantidade de morbidades e mortes. Uma das manifestações das formas graves da doença é o estado trombofílico, que pode provocar danos em vários sistemas. Este artigo relata o caso de uma paciente do sexo feminino, 60 anos de idade, que foi internada em um serviço hospitalar privado com sintomas gripais inespecíficos leves, mas que progrediu com trombose arterial e isquemia de membros causada pelo SARS-CoV2. Devido à essa evolução, foi optada pela administração concomitante de heparina de baixo peso molecular e Alprostadil, com bom desfecho clínico. Nossa descrição objetiva identificar pontos-chave e sinais clínicos que evidenciem essa janela terapêutica, bem como uma opção de tratamento para as apresentações coagulatórias da COVID-19.


COVID-19, tromboembolismo, isquemia de membros, trombose arterial, heparina


1 Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. PMid:32171076.

2 Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-20. PMid:32172226.

3 Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, et al. Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol. 2020;83(3):e241. PMid:32497704.

4 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. PMid:32073213.

5 Walls AC, Park Y, Tortorici M, Wall A, McGuire A, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292.e6. PMid:32155444.

6 Li MY, Li L, Zhang Y, Wang X. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. PMid:32345362.

7 Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8. PMid:32161940.

8 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. PMid:31986264.

9 Arantes F. Efeito dos anticoagulantes sobre a agregabilidade plaquetária: ação da heparina de baixo peso molecular Enoxaparina, e do inibidor direto da trombina Dabigatrana [tese]. São Paulo: Universidade de São Paulo; 2018.

10 Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thromb Haemost. 2020;18(5):1023-6. PMid:32338827.

11 Shi C, Wang C, Wang H et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study. medRxiv. 2020;1-11.

12 Gajic O, Dara SI, Mendez JL, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004;32(9):1817-24. PMid:15343007.

13 Li L-F, Liu Y, Lin S, et al. Low-molecular-weight heparin reduces ventilation-induced lung injury through hypoxia inducible factor-1α in a murine endotoxemia model. Int J Mol Sci. 2020;21(9):3097. PMid:32353952.

14 National Center for Biotechnology Information. [site na Internet]. Alprostadil. Bethesda: National Center for Biotechnology Information; 2020. [cited 2020 may 31].

15 Yan X, Li Y, Choi Y, et al. Protective effect and mechanism of alprostadil in acute respiratory distress syndrome induced by oleic acid in rats. Med Sci Monit. 2018;24:7186-98. PMid:30296789.

16 Mayer K, Schmidt R, Muhly-Reinholz M, et al. In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFα impact of ω-3 versus ω-6 fatty acids. J Lipid Res. 2002;43(6):944-51. PMid:12032170.

17 Olivecrona T, Egelrud T, Iverius P, Lindahl U. Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun. 1971;43(3):524-9. PMid:5563304.

18 Sweeney RM, Griffiths M, McAuley D. Treatment of acute lung injury: current and emerging pharmacological therapies. Semin Respir Crit Care Med. 2013;34(4):487-98. PMid:23934717.

19 Iba T, Levy J. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283-94. PMid:30582882.

20 Burzynski LC, Humphry M, Pyrillou K, et al. The coagulation and immune systems are directly linked through the activation of interleukin-1α by thrombin. Immunity. 2019;50(4):1033-1042.e6. PMid:30926232.

21 Figueiredo LT. Viral hemorrhagic fevers in Brazil. Rev Soc Bras Med Trop. 2006;39(2):203-10. PMid:16699651.

22 Jia Y, Chen K, Lin P, et al. Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat Commun. 2014;5(1):4387. PMid:25034454.

23 Pan A, Liu L, Wang C et al. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020;323(19):1915-1923.

24 Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19. Allergy. 2020;75(7):1564-81. PMid:32396996.

25 Arnaldez FI, O’Day S, Drake C, et al. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer. 2020;8(1):e000930. PMid:32385146.

26 Mann S, Jones R, Millar-Craig M, Wood C, Gould B, Raftery E. The safety of ambulatory intra-arterial pressure monitoring: a clinical audit of 1000 studies. Int J Cardiol. 1984;5(5):585-97. PMid:6715074.

27 Iba T, Levy J. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283-94. PMid:30582882.

5fbfc00d0e8825406bf5cc94 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections